🏥 Health 3d ago

Twice-Rejected Melanoma Drug Gets Love From FDA Panel

MedPage Today
Medical news for professionals
View Channel →
Twice-Rejected Melanoma Drug Gets Love From FDA Panel
Source ↗ 👁 1 💬 0
(MedPage Today) -- In the wake of a surprise FDA advisory committee vote on Thursday, the third time could be the charm for RP1 (vusolimogene oderparepvec), a melanoma drug candidate that's already been rejected twice by the agency.
Despite doubts...

Comments (0)

Sign in to join the discussion

More Like This

When 'I Appreciate You' Feels Hollow
Psychology Today: The Latest · 1d ago
Why Every Patient Needs an AI Zebra Scan
Psychology Today: The Latest · 1d ago
Why Do I Hate Pictures of Myself?
Psychology Today: The Latest · 1d ago
Guaranteed Ways to Make Yourself Anxious
Psychology Today: The Latest · 1d ago
What Can You Learn From Your Indecision?
Psychology Today: The Latest · 1d ago
Long-Acting Lenacapavir Still Delivered Effective HIV PrEP After a Year
MedPageToday.com - medical news for physicians · 1d ago